0
Back To Top Jump Location
Sign In  | Cart
Journals | Topic Collections | CME | Guidelines | Subscribe
Left Shadow
Right Shadow
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Clinical Research |  May 21, 2013
Targeting P-Selectin During Coronary Interventions: The Elusive Link Between Inflammation and Platelets to Prevent Myocardial Damage⁎⁎ 
Fernando Alfonso, MD, PhD; Dominick J. Angiolillo, MD, PhD
J Am Coll Cardiol. 2013;61(20):2056-2059. doi:10.1016/j.jacc.2013.03.004.
Clinical Research |  May 21, 2013
Triple Antithrombotic Therapy With Prasugrel in the Stented Patient: Concern for More Bleeding⁎⁎ 
Paul A. Gurbel, MD; Udaya S. Tantry, PhD
J Am Coll Cardiol. 2013;61(20):2067-2069. doi:10.1016/j.jacc.2013.02.032.
Clinical Research |  May 21, 2013
Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation
Nikolaus Sarafoff, MD; Amadea Martischnig, MD; Jill Wealer, MS; et al.
J Am Coll Cardiol. 2013;61(20):2060-2066. doi:10.1016/j.jacc.2013.02.036.
Clinical Research |  May 14, 2013
Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
Jonathan P. Piccini, MD, MHS; Susanna R. Stevens, MS; Yuliya Lokhnygina, PhD; et al.
J Am Coll Cardiol. 2013;61(19):1998-2006. doi:10.1016/j.jacc.2013.02.025.
Clinical Research |  May 07, 2013
Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction: Results From the ATLAS ACS-2–TIMI-51 Trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome–Thrombolysis In Myocardial Infarction-51)
Jessica L. Mega, MD, MPH; Eugene Braunwald, MD; Sabina A. Murphy, MPH; et al.
J Am Coll Cardiol. 2013;61(18):1853-1859. doi:10.1016/j.jacc.2013.01.066.
INCLUDES: Supplemental Content
Clinical Research |  May 07, 2013
Pre-Procedural Estimate of Individualized Bleeding Risk Impacts Physicians' Utilization of Bivalirudin During Percutaneous Coronary Intervention
Seshu C. Rao, MD; Adnan K. Chhatriwalla, MD; Kevin F. Kennedy, MS; et al.
J Am Coll Cardiol. 2013;61(18):1847-1852. doi:10.1016/j.jacc.2013.02.017.
Clinical Research |  April 30, 2013
Quality of Life Assessment in the Randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Trial of Patients at Risk for Stroke With Nonvalvular Atrial Fibrillation
Oluseun Alli, MD; Shepal Doshi, MD; Saibal Kar, MD; et al.
J Am Coll Cardiol. 2013;61(17):1790-1798. doi:10.1016/j.jacc.2013.01.061.
Practice Guideline |  April 29, 2013 FREE ONLINE FIRST
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Hani Jneid, MD, FACC, FAHA; Jeffrey L. Anderson, MD, FACC, FAHA; R. Scott Wright, MD, FACC, FAHA,; et al.
J Am Coll Cardiol. 2013;():. doi:10.1016/j.jacc.2013.01.014.
Clinical Research |  April 17, 2013 ONLINE FIRST
Left Atrial Appendage Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation: ASA Plavix Feasibility Study with Watchman Left Atrial Appendage Closure Technology (ASAP Study)
Vivek Y. Reddy, MD; Sven Möbius-Winkler, MD; Marc A. Miller, MD; et al.
J Am Coll Cardiol. 2013;():. doi:10.1016/j.jacc.2013.03.035.
Clinical Research |  April 16, 2013
Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) Primary PCI Study
Guido Parodi, MD, PhD; Renato Valenti, MD; Benedetta Bellandi, MD; et al.
J Am Coll Cardiol. 2013;61(15):1601-1606. doi:10.1016/j.jacc.2013.01.024.
Left Shadow
Right Shadow
logo © 2013 American College of Cardiology Foundation
Powered bySilverchair Information Systems